Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma: Current Evidence and Future Directions

por Sammarco, Enrico, Manfredi, Fiorella, Nuzzo, Amedeo, Ferrari, Marco, Bonato, Adele, Salfi, Alessia, Serafin, Debora, Zatteri, Luca, Antonuzzo, Andrea, Galli, Luca
Publicado 2023

Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies

por Caruso, Teresita, Salani, Francesca, Catanese, Silvia, Pratesi, Federico, Mercinelli, Chiara, Motta, Giuseppe, Genovesi, Virginia, Bonato, Adele, Sara, Galimberti, Masi, Gianluca, Migliorini, Paola
Publicado 2023

Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies

por Caruso, Teresita, Salani, Francesca, Catanese, Silvia, Pratesi, Federico, Mercinelli, Chiara, Motta, Giuseppe, Genovesi, Virginia, Bonato, Adele, Sara, Galimberti, Masi, Gianluca, Migliorini, Paola
Publicado 2023

Safety and Tolerability of COVID-19 Vaccines in Patients with Cancer: A Single Center Retrospective Analysis

por Nuzzo, Amedeo, Manacorda, Simona, Sammarco, Enrico, Sbrana, Andrea, Bazzurri, Serena, Paolieri, Federico, Manfredi, Fiorella, Mercinelli, Chiara, Ferrari, Marco, Massaro, Giulia, Bonato, Adele, Salfi, Alessia, Galli, Luca, Morganti, Riccardo, Antonuzzo, Andrea, Cremolini, Chiara, Masi, Gianluca
Publicado 2022